Alkira Bio

About

Alkira Bio develops the LASEREDD platform to discover therapeutic antibodies targeting complex membrane proteins that are challenging for conventional discovery methods.

Mission

Alkira Bio develops the LASEREDD® platform to discover therapeutic antibodies directed against complex membrane proteins. The platform is positioned to address targets that are difficult for conventional discovery approaches. The company plans to expand LASEREDD® capabilities using proceeds from a recently announced seed investment. The funding is intended to accelerate discovery efforts and advance programs toward therapeutic development. Alkira's stated goal is to leverage its platform to deliver breakthrough medicines that improve patients' lives. No operating metrics or financial details were disclosed in the article.

Quick Facts